A stable intramolecular complex comprising the LIM domains of the LIMhomeodomain protein Isl1 tethered to a peptide region of Ldb1 has been engineered, purified and crystallized. The orthorhombic crystals belonged to space group P222 1 , with unit-cell parameters a = 57.2, b = 56.7, c = 179.8 Å , and diffracted to 3.10 Å resolution.
Introduction
The LIM-homeodomain family of transcription factors is responsible for many cell-fate decisions within developing cells and tissues (Hunter & Rhodes, 2005) . LIM-homeodomain proteins are named for the pair of N-terminal LIM domains and the centrally located homeodomain in each family member. They also contain poorly characterized C-terminal regions. The LIM domains are zinc fingers that coordinate two zinc ions and mediate protein-protein interactions. The acronym 'LIM' is generated from the genes lin-1, isl-1 and mec-3, which were the first in which these domains were identified (Bach, 2000; Way & Chalfie, 1988; Freyd et al., 1990; Karlsson et al., 1990) . The homeodomains are DNA-binding domains that specifically target AT-rich sites.
The LIM-homeodomain protein Islet-1 (Isl1) was first isolated as a binding protein of the rat insulin I gene enhancer sequence (Karlsson et al., 1990) . The protein is critical for many developmental processes. In the pancreas Isl1 is necessary for the development of pancreatic mesenchyme and the formation of all endocrine islet cells (Ahlgren et al., 1997) . In the heart, Isl1 is associated with the secondary heart field. Isl1-expressing cardiac progenitors develop into the outflow tract, right ventricle and atria in the heart, none of which form in mice lacking Isl1 (Cai et al., 2003) . In the developing central nervous system Isl1 and its paralogue Isl2 are required to specify motor neuron cell fate (Pfaff et al., 1996; Thaler et al., 2004) . In Isl1 À/À mice pituitary development is stalled at the rudimentary stage of Rathke's pouch (Takuma et al., 1998) .
The biological activity of Isl1 depends on its interaction with LIM-domain-binding protein 1 (Ldb1), an essential cofactor of LIM-homeodomain proteins (Matthews & Visvader, 2003) . In motor neurons, Isl1 also binds a second LIM-homeodomain protein, Lhx3, and the formation of a ternary Ldb1-Isl1-Lhx3 complex is essential for correct cell-fate determination (Thaler et al., 2002) . Isl1 and Lhx3 are also coexpressed in the early stages of Rathke's pouch formation, suggesting that the same complex may be required in the pituitary (Ericson et al., 1998) . Within this complex the LIM domains from Isl1 bind to the LIM-interaction domain (LID) of Ldb1 (Ldb1 LID ), while the LIM domains from Lhx3 bind to the LID-like Lhx3-binding domain (LBD) in Isl1 (Isl1 LBD ) ( Fig. 1 ; Bhati, Lee, Nancarrow, Jurata & Gill, 1997) . The formation of the ternary complex appears to be driven, at least in part, by binding to Isl1-Lhx3-specific recognition sites on DNA, such as those found in the promoter of the motor neuron-specific gene Hb9 Thaler et al., 2002; Lee et al., 2008) .
We have previously determined the structure of an Lhx3-Isl1 LBD subcomplex of the ternary complex (PDB entry 2rgt; Bhati, Lee, Nancarrow, Lee et al., 2008) and have determined structures of related complexes for the LIM domains of the LIM-only protein LMO4 in complex with Ldb1 LID (PDB entry 1rut; Deane et al., 2004) , Lhx4 in complex with Isl2 LBD (PDB entry 3mmk; Gadd et al., 2011) and the solution structure of Lhx3 in complex with Ldb1 LID (PDB entry 2jtn; Bhati, Lee, Nancarrow, Lee et al., 2008) . Others have determined the structure of a similar complex between LMO2 and Ldb1 LID (El Omari et al., 2011) . Here, we report the successful purification and crystallization of a tethered complex of the LIM domains of Isl1 and Ldb1 LID , which represents the remaining LIMcontaining subcomplex in the ternary complex, and present a preliminary analysis of the diffraction data obtained.
Methods

Cloning, expression and purification
A construct containing residues 11-138 of murine Isl1 (NCBI entry NP_067434), a linker encoding GGSGGHMGSGGG and residues 300-330 of Ldb1 (NCBI entry NP_034827.1) was cloned into a pGEX-2T vector (GE Healthcare) for expression with an N-terminal glutathione S-transferase (GST) tag. Protein expression from this plasmid was carried out in Escherichia coli BL21 (DE3) cells in Luria broth using 0.4 mM IPTG induction for 20 h at 293 K. Purification was carried out as described for Lhx4-Isl2 in Gadd et al. (2009) . In brief, cells were lysed by freeze-thawing and sonication and GST-Isl1-Ldb1 was purified by affinity chromatography using glutathione Sepharose 4B resin (GE Healthcare). Thrombin was used to remove the GST tag, leaving two additional residues (GS) at the N-terminus of Isl1-Ldb1. Size-exclusion chromatography on a HiLoad 16/60 Superdex 200 column (GE Healthcare) was used to further purify the protein in a buffer composed of 20 mM Tris-HCl pH 8.0, 150 mM NaCl and 1 mM dithiothreitol. Additionally, the protein was then passed over glutathione resin once more to remove small amounts of contaminating GST. The purified protein was concentrated with centrifugal filtration devices (Vivaspin 6, GE Healthcare) to a concentration of $10 mg ml À1 in the same buffer prior to crystallization. The protein concentration was determined spectrophotometrically from the absorbance at 280 nm (NanoDrop ND-1000 Spectrophotometer, Biolab) using a theoretical extinction coefficient of 14 440 M À1 cm À1 .
Crystallization
Commercial sparse-matrix crystallization screens (Qiagen) were used to explore preliminary crystallization conditions. A Mosquito positive-displacement liquid-handling robot (TTP LabTech) was used to combine equal volumes (400 nl) of crystallization conditions and protein solution ($10 mg ml À1 ) suspended above well solutions (75 ml) in hanging-drop 96-well format trays. The trays were incubated at room temperature ($293 K). Crystal optimization was achieved by large-scale hanging-drop experiments in which a total of 4 ml of protein and well solutions were combined in ratios of 1:1-8, respectively, and equilibrated against 0.5 or 1 ml of well solution at room temperature.
Data collection and processing
The crystal was cryoprotected by soaking it in a solution of 20% 2-methyl-2,4-pentanediol/80% well solution prior to flash-cooling in a nitrogen-gas stream at 100 K. Diffraction data were recorded on the Australian Synchrotron beamline MX2 with a Quantum 315 CCD detector (ADSC) using Blu-Ice software (McPhillips et al., 2002) . A fluorescence excitation scan was performed to determine the position of the zinc edge; however, owing to instrumentation issues the data were inconclusive and theoretical values were primarily used to determine wavelengths for data collection. Sequentially, 720 frames were recorded at a crystal-to-detector distance of 280 mm and a wavelength of 1.2816 Å (zinc peak), 360 frames were recorded at a crystal-to-detector distance of 400 mm and a wavelength of 0.9537 Å (remote) and 720 frames were recorded at a crystal-to-detector distance of 280 mm and a wavelength of 1.2826 Å (zinc inflection). The resolution limits for the zinc peak/inflection and remote frames were 2.53 and 2.56 Å , respectively. An oscillation range of 0.5 and 1 s exposure were used for each frame. The diffraction data were integrated and scaled using the HKL-2000 package (Otwinowski & Minor, 1997) .
Results and discussion
A complex comprising the LIM domains of Isl1 and Ldb1 LID was generated. When expressed recombinantly, LIM domains from LIMhomeodomain and LIM-only proteins tend to be insoluble; however, by tethering the LIM domains to an interacting peptide a stable complex may be produced Deane et al., 2001) . Thus, the LIM domains of Isl1 were fused, via a flexible 12-residue linker, to Ldb1 LID in that order (Isl1-Ldb1). The tethered Isl1-Ldb1 complex (19 600 Da) was produced with yields of $3-4 mg protein per litre of medium and >95% purity as determined by SDS-PAGE with Coomassie staining.
Initial crystallization screening resulted in small crystals after 3-5 d under one of 864 conditions trialled: Qiagen JCSG+ Suite condition No. 42 [20%(w/v) polyethylene glycol 8000, 0.2 M magnesium chloride, 0.1 M Tris pH 8.5]. Optimization of JCSG+ Suite condition No. 42 yielded an array of conditions that produced clustered crystals in a variety of shapes with maximum dimension $200 mm after 1-2 weeks: 16-24%(w/v) polyethylene glycol 8000, 0.2 M magnesium chloride, 0.1 M Tris-HCl pH 8.1-9.1, 1:1-5 protein:well solution (Fig. 2) . No obvious relationships between crystallization conditions and crystal morphology were observed. Data were recorded from a single crystal obtained using conditions consisting of 20%(w/v) polyethylene glycol 8000, 0.2 M magnesium chloride, 0.1 M Tris-HCl pH 8.9, 0.3 mM zinc sulfate. The crystal was obtained from a cluster similar to that in Fig. 2(c) by tapping the common nucleus to separate the crystals from each other and from the skin of denatured protein on the surface of the drop.
Diffraction data were recorded as described. The accumulation of radiation damage was observed during the collection of the 'zinc peak' data (1.2816 Å ). Following data scaling, higher R merge values were calculated when all 720 frames (360 ) of the data were used compared with the first 360 frames (180 ) of the data. Additionally, the scaling B-factor values increased dramatically between frame 360 (180 total oscillation) and frame 720 (360 ) (Fig. 3) . Because of the observation of radiation damage in the zinc peak data, the subsequent data sets (remote and zinc inflection) were not considered to be suitable for use in structure determination or refinement.
All 720 frames (360 ) of the zinc peak data were scaled together and the resulting data-collection and processing statistics are summarized in Table 1 . The crystals were primitive orthorhombic, with unit-cell parameters a = 57.2, b = 56.7, c = 179.8 Å , and diffracted to 3.10 Å resolution (Fig. 4) . Based on observed systematic absences the space group is predicted to be P222 1 . Three molecules are predicted within the asymmetric unit, resulting in a corresponding specific volume of 2.5 Å 3 Da À1 and a solvent content of 50.3% (Matthews, 1968) .
We will use the anomalous signal at 1.2816 Å to build a heavy-atom substructure from the 12 Zn atoms in the asymmetric unit. We will attempt experimental phasing using the complete 720 frames for the Scaling B factors plotted against frame number for the zinc peak data set.
Figure 4
Diffraction image of the Isl1-Ldb1 complex. The inset shows visible data at higher resolution. roughly 4 Å resolution ( Fig. 5 ; Sheldrick, 2008) . Should the anomalous signal prove insufficient, we will endeavour to overcome the phase problem using molecular replacement (MR) and the available homologous structures Deane et al., 2004; El Omari et al., 2011; Gadd et al., 2011) . Based on our previous experience attempting MR on these structures, we anticipate such an approach to be difficult. We intend to refine any resulting structure against a smaller scaled data set excluding frames exhibiting radiation damage.
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